iconstar paper   HIV Articles  
Back grey arrow rt.gif
 
 
Treatment Adherence and Virologic Response Over 48 Weeks Among Patients Rapidly Initiating Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in the DIAMOND Study
 
 
  Reported by Jules Levin
 
14TH INTERNATIONAL CONFERENCE ON HIV TREATMENT AND PREVENTION ADHERENCE; JUNE 17-19, 2019; MIAMI, FLORIDA Hélène Hardy,1,* Donghan Luo,2 Debra Israel,1 Richard Bruce Simonson,1 Keith Dunn1 1Janssen Scientific Affairs, LLC, Titusville, NJ; 2Janssen Research & Development, LLC, Titusville, NJ.

0801191

0801192

0801193

0801194

0801195

0801196

0801197

0801198

0801199

08011910

08011911

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org